secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tvardi Therapeutics, Inc. (TVRD)
CIK:        0001346830
Form:       8-K
Filed at:   2026-07-17T20:07:52+00:00
Accession:  0001104659-26-084627
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tvardi Therapeutics increases ATM offering by up to $9.7M
---------------------------------------------------------

- Filed prospectus supplement to increase ATM offering capacity by $9,689,765 in common stock.
- Prior 12-month sales under existing program: 3,110,769 shares for ~$11.0M gross proceeds.
- Offering subject to 'baby shelf' rule; non-affiliate market value $62.2M based on 12.4M shares at $5.00.
- No additional shares will be sold under prior prospectus after supplement date.
- Legal opinion from Cooley LLP filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1346830/000110465926084627/0001104659-26-084627-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1346830/000110465926084627/tm2620743d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-084627

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer